Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Filtered by score tier "Top 90+", profit streak "Full 10 yr", No report yet: 36 match(clear filters).

# Ticker Mkt Cap Score 10Y ROE Profit Streak Net Debt/Eq Gross Margin Report FY
1 Check Point Software Technologies Ltd CHKP · US $13B
97/100 Elite
26.1%low 20.8% 10 yr+ Net cash 88% FY2025
2 AJ Bell plc AJB · LSE $2.9B
97/100 Elite
35.9%low 24.8% 10 yr+ Net cash 100% FY2025
3 Federated Investors Inc B FHI · US $4.6B
96/100 Elite
28.6%low 22.9% 10 yr+ Net cash 68% FY2025
4 Manhattan Associates Inc MANH · US $11B
95/100 Elite
56.1%low 39.9% 10 yr+ Net cash 54% FY2025
5 Paycom Software, Inc. PAYC · US $7.6B
95/100 Elite
28.8%low 21.9% 10 yr+ Net cash 84% FY2025
6 WD-40 Company WDFC · US $3.0B
95/100 Elite
36.0%low 30.2% 10 yr+ 0.1× 54% FY2025
7 National Beverage Corp FIZZ · US $3.0B
95/100 Elite
41.0%low 28.7% 10 yr+ Net cash 37% FY2026
8 Hansoh Pharmaceutical Group Co Ltd 3692 · HK $25B
94/100 Elite
26.3%low 11.4% 10 yr+ Net cash 91% FY2025
9 Rightmove PLC RMV · LSE $4.4B
94/100 Elite
60.0%low 60.0% 10 yr+ Net cash 100% FY2025
10 Exponent Inc EXPO · US $3.2B
94/100 Elite
26.7%low 22.8% 10 yr+ Net cash 60% FY2025
11 Hermes International SCA RMS · Paris $173B
93/100 Elite
24.9%low 18.8% 10 yr+ Net cash 68% FY2025
12 Nemetschek AG O.N. NEM · XETRA $7.2B
93/100 Elite
26.3%low 19.4% 10 yr+ 0.2× 53% FY2025
13 MarketAxess Holdings Inc MKTX · US $5.7B
93/100 Elite
25.1%low 19.7% 10 yr+ Net cash 77% FY2025
14 Shenzhen New Industries Biomedical 300832 · Shenzhen $5.3B
93/100 Elite
23.5%low 17.4% 10 yr+ Net cash 75% FY2025
15 Proya Cosmetics Co Ltd Class A 603605 · Shanghai $3.3B
93/100 Elite
22.1%low 13.8% 10 yr+ Net cash 66% FY2025
16 NetEase Inc 9999 · HK $85B
92/100 Elite
22.0%low 13.6% 10 yr+ Net cash 57% FY2025
17 Deutsche Börse AG DB1 · XETRA $51B
92/100 Elite
18.7%low 16.8% 10 yr+ Net cash 59% FY2025
18 Foshan Haitian Flavouring and Food Co Ltd 603288 · Shanghai $31B
92/100 Elite
26.3%low 17.0% 10 yr+ Net cash 41% FY2025
19 ANTA Sports Products Ltd 2020 · HK $28B
92/100 Elite
23.7%low 19.9% 10 yr+ Net cash 57% FY2025
20 SEI Investments Company SEIC · US $12B
92/100 Elite
27.0%low 21.7% 10 yr+ Net cash 60% FY2025
21 Genpact Limited G · US $5.1B
92/100 Elite
20.4%low 16.8% 10 yr+ 0.2× 36% FY2025
22 Zhejiang Weixing New Building Materials Co Ltd 002372 · Shenzhen $2.0B
92/100 Elite
23.9%low 15.2% 10 yr+ Net cash 43% FY2025
23 Kainos Group PLC KNOS · LSE $1.3B
92/100 Elite
34.4%low 25.8% 10 yr+ Net cash 48% FY2026
24 Adyen NV ADYEN · Amsterdam $30B
91/100 Elite
23.4%low 18.3% 10 yr+ Net cash 72% FY2025
25 Gongniu Group Co Ltd 603195 · Shanghai $11B
91/100 Elite
36.5%low 24.2% 10 yr+ Net cash 41% FY2025
26 Jiangsu King's Luck Brewery Joint-Stock Co Ltd 603369 · Shanghai $5.0B
91/100 Elite
19.7%low 15.7% 10 yr+ Net cash 74% FY2025
27 Hubei Jumpcan Pharmaceutical Co Ltd 600566 · Shanghai $3.4B
91/100 Elite
21.6%low 12.2% 10 yr+ Net cash 83% FY2025
28 MONY Group plc MONY · LSE $1.3B
91/100 Elite
37.1%low 25.9% 10 yr+ 0.1× 66% FY2025
29 Barrett Business Services Inc BBSI · US $959M
91/100 Elite
24.9%low 17.0% 10 yr+ Net cash 21% FY2025
30 Evercore Partners Inc EVR · US $12B
90/100 Elite
28.4%low 13.7% 10 yr+ Net cash 99% FY2025
31 Orion Oyj B ORNBV · HE $12B
90/100 Elite
33.1%low 24.4% 10 yr+ 0.1× 60% FY2025
32 IMI PLC IMI · LSE $8.8B
90/100 Elite
24.4%low 21.3% 10 yr+ 0.5× 45% FY2025
33 Chemed Corp CHE · US $7.1B
90/100 Elite
29.2%low 18.2% 10 yr+ 0.1× 33% FY2025
34 Howden Joinery Group Plc HWDN · LSE $5.5B
90/100 Elite
32.1%low 20.5% 10 yr+ 0.3× 62% FY2025
35 Ninety One PLC N91 · LSE $2.7B
90/100 Elite
51.3%low 21.9% 10 yr+ Net cash 64% FY2026
36 Hangzhou Robam Appliances Co Ltd 002508 · Shenzhen $2.1B
90/100 Elite
19.8%low 10.9% 10 yr+ Net cash 53% FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.